SCOTLANDI, KATIA
SCOTLANDI, KATIA
ARAG - AREA FINANZA E PARTECIPATE
Collaboratori
Abstract 3201: Insulin-like growth factor 2 (IGF-2) mRNA binding protein 3 predicts poor prognosis and promotes cell proliferation in Ewing sarcoma
2016-01-01 Mancarella, Caterina; Calzolari, Linda; Ferrari, Stefano; Donati, Davide; Picci, Piero; Scotlandi, Katia
Altered modulation of lamin A/C-HDAC2 interaction and p21 expression during oxidative stress response in HGPS
2018-01-01 Mattioli, Elisabetta; Andrenacci, Davide; Garofalo, Cecilia; Prencipe, Sabino; Scotlandi, Katia; Remondini, Daniel; Gentilini, Davide; Di Blasio, Anna Maria; Valente, Sergio; Scarano, Emanuela; Cicchilitti, Lucia; Piaggio, Giulia; Mai, Antonello; Lattanzi, Giovanna
Apoptotic genes as potential markers of metastatic phenotype in human osteosarcoma cell lines.
2008-01-01 Zucchini C.; Rocchi A.; Manara M.C.; De Sanctis P.; Capanni C.; Bianchini M.; Carinci P.; Scotlandi K.; Valvassori L.
An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas.
2014-01-01 Guerzoni C;Amatori S;Giorgi L;Manara MC;Landuzzi L;Lollini PL;Tassoni A;Balducci M;Manfrini M;Pratelli L;Serra M;Picci P;Magnani M;Fusi V;Fanelli M;Scotlandi K
Biological indicators of prognosis in Ewing’s sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP).
2010-01-01 D. Zambelli; M. Zuntini; F. Nardi; M.C. Manara; M. Serra; L. Landuzzi; P.-L. Lollini; S. Ferrari; M. Alberghini; A. Llombart-Bosch; E. Piccolo; S. Iacobelli; P. Picci; K. Scotlandi.
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations
2019-01-01 Nanni, Patrizia; Landuzzi, Lorena; Manara, Maria Cristina; Righi, Alberto; Nicoletti, Giordano; Cristalli, Camilla; Pasello, Michela; Parra, Alessandro; Carrabotta, Marianna; Ferracin, Manuela; Palladini, Arianna; Ianzano, Marianna L; Giusti, Veronica; Ruzzi, Francesca; Magnani, Mauro; Donati, Davide Maria; Picci, Piero; Lollini, Pier-Luigi; Scotlandi, Katia
Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling
2007-01-01 Cantiani L.; Manara M.C.; Zucchini C.; De Sanctis P.; Zuntini M.; Valvassori L.; Serra M.; Olivero M.; Di Renzo M.F.; Colombo M.P.; Picci P.; Scotlandi K.
CD99 Acts as an Oncosuppressor in Osteosarcoma.
2006-01-01 Manara M.C.; Bernard G.; Lollini P.L.; Nanni P.; Zuntini M.; Landuzzi L.; Benini S.; Lattanzi G.; Sciandra M.; Serra M.; Colombo M.P.; Bernard A.; Picci P.; Scotlandi K.
CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2.
2014-01-01 Sciandra M;Marino MT;Manara MC;Guerzoni C;Grano M;Oranger A;Lucarelli E;Lollini PL;Dozza B;Pratelli L;Renzo MF;Colombo MP;Picci P;Scotlandi K
CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity
2007-01-01 Scotlandi K; Zuntini M; Manara MC; Sciandra M; Rocchi A; Benini S; Nicoletti G; Bernard G; Nanni P; Lollini PL; Bernard A; Picci P
CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity.
2014-01-01 Zucchini C;Manara MC;Pinca RS;De Sanctis P;Guerzoni C;Sciandra M;Lollini PL;Cenacchi G;Picci P;Valvassori L;Scotlandi K
Cell growth inhibition and apoptotic effect of the rexinoid 6-OH-11-O-hydroxyphenantrene on human osteosarcoma and mesenchymal stem cells.
2012-01-01 Dozza B.; Papi A.; Lucarelli E.; Scotlandi K.; Pierini M.; Tresca G.; Donati D.; Orlandi M.
Characterization of human mesenchymal stem cells from Ewing sarcoma patients. Pathogenetic implications
2014-01-01 Amaral, A.T.A.; Manara, M.C.; Berghuis, D.; Ordonez, J.L.; Biscuola, M.; Lopez-Garcia, M.A.; Osuna, D.; Lucarelli, E.; Alviano, F.; Lankester, A.; Scotlandi, K.; De Alava, E.
Circulating miR34a levels as a potential biomarker in the follow-up of Ewing sarcoma
2020-01-01 Sciandra M.; De Feo A.; Parra A.; Landuzzi L.; Lollini P.-L.; Manara M.C.; Mattia G.; Pontecorvi G.; Baricordi C.; Guerzoni C.; Bazzocchi A.; Longhi A.; Scotlandi K.
Does MGMT (O6-methylguanine–DNA methyltransferase) have a role in metastatic Ewing sarcoma (ES) patients (pts) undergoing temozolomide (TMZ) and irinotecan (IRI)?
2017-01-01 Emanuela Palmerini; Michela Pasello; Robin Lewis Jones; Maria Cristina Manara; Alessandro Parra; Piero Picci; Giovanni Grignani; Emanuela Marchesi; Marilena Cesari; Alessandra Longhi; Massimo Abate; Anna Paioli; Lorenzo D'Ambrosio; Franca Fagioli; Asaftei sebastian Dorin; Stefano Ferrari; Katia Scotlandi
Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation
2019-01-01 De Feo A.; Sciandra M.; Ferracin M.; Felicetti F.; Astolfi A.; Pignochino Y.; Picci P.; Care A.; Scotlandi K.
Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cells.
2014-01-01 Contaldo C;Myers TJ;Zucchini C;Manara MC;Chiodoni C;Colombo MP;Nicoletti G;Lollini PL;Li T;Longobardi L;Scotlandi K;Spagnoli A
Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells
2002-01-01 Scotlandi K.; Avnet S.; Benini S.; Manara M.C.; Serra M.; Cerisano V.; Perdichizzi S.; Lollini P.-L.; De Giovanni C.; Landuzzi L.; Picci P.
High metastatic efficiency of human sarcoma cells in Rag2/gamma c double knockout mice provides a powerful test system for antimetastatic targeted therapy
2010-01-01 P. Nanni; G. Nicoletti; L. Landuzzi; S. Croci; A. Murgo; A. Palladini; A. Antognoli; M.L. Ianzano; V. Stivani; V. Grosso; S.-M. Maira; C. García-Echeverría; K. Scotlandi; C. De Giovanni; P.-L. Lollini
Identification of candidate genes involved in the reversal of malignant phenotype of osteosarcoma cells transfected with the liver/bone/kidney alkaline phosphatase gene
2004-01-01 ZUCCHINI C.; BIANCHINI M.; VALVASSORI L.; PERDICHIZZI S.; BENINI S.; MANARA MC.; SOLMI R.; STRIPPOLI P.; PICCI P.; CARINCI P.; SCOTLANDI K.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Abstract 3201: Insulin-like growth factor 2 (IGF-2) mRNA binding protein 3 predicts poor prognosis and promotes cell proliferation in Ewing sarcoma | Mancarella, Caterina; Calzolari, Linda; Ferrari, Stefano; Donati, Davide; Picci, Piero; Scotlandi..., Katia | 2016-01-01 | CANCER RESEARCH | - | 1.06 Abstract in rivista | - |
| Altered modulation of lamin A/C-HDAC2 interaction and p21 expression during oxidative stress response in HGPS | Mattioli, Elisabetta; Andrenacci, Davide; Garofalo, Cecilia; Prencipe, Sabino; Scotlandi, Katia; ...Remondini, Daniel; Gentilini, Davide; Di Blasio, Anna Maria; Valente, Sergio; Scarano, Emanuela; Cicchilitti, Lucia; Piaggio, Giulia; Mai, Antonello; Lattanzi, Giovanna | 2018-01-01 | AGING CELL | - | 1.01 Articolo in rivista | HDAC progerici_Lattanzi Remondini_AgingCell18.pdf |
| Apoptotic genes as potential markers of metastatic phenotype in human osteosarcoma cell lines. | Zucchini C.; Rocchi A.; Manara M.C.; De Sanctis P.; Capanni C.; Bianchini M.; Carinci P.; Scotlan...di K.; Valvassori L. | 2008-01-01 | INTERNATIONAL JOURNAL OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas. | Guerzoni C;Amatori S;Giorgi L;Manara MC;Landuzzi L;Lollini PL;Tassoni A;Balducci M;Manfrini M;Pra...telli L;Serra M;Picci P;Magnani M;Fusi V;Fanelli M;Scotlandi K | 2014-01-01 | BMC CANCER | - | 1.01 Articolo in rivista | 1471-2407-14-137.pdf |
| Biological indicators of prognosis in Ewing’s sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP). | D. Zambelli; M. Zuntini; F. Nardi; M.C. Manara; M. Serra; L. Landuzzi; P.-L. Lollini; S. Ferrari;... M. Alberghini; A. Llombart-Bosch; E. Piccolo; S. Iacobelli; P. Picci; K. Scotlandi. | 2010-01-01 | INTERNATIONAL JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations | Nanni, Patrizia; Landuzzi, Lorena; Manara, Maria Cristina; Righi, Alberto; Nicoletti, Giordano; C...ristalli, Camilla; Pasello, Michela; Parra, Alessandro; Carrabotta, Marianna; Ferracin, Manuela; Palladini, Arianna; Ianzano, Marianna L; Giusti, Veronica; Ruzzi, Francesca; Magnani, Mauro; Donati, Davide Maria; Picci, Piero; Lollini, Pier-Luigi; Scotlandi, Katia | 2019-01-01 | SCIENTIFIC REPORTS | - | 1.01 Articolo in rivista | PDX bone Sci Rep.pdf |
| Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling | Cantiani L.; Manara M.C.; Zucchini C.; De Sanctis P.; Zuntini M.; Valvassori L.; Serra M.; Oliver...o M.; Di Renzo M.F.; Colombo M.P.; Picci P.; Scotlandi K. | 2007-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| CD99 Acts as an Oncosuppressor in Osteosarcoma. | Manara M.C.; Bernard G.; Lollini P.L.; Nanni P.; Zuntini M.; Landuzzi L.; Benini S.; Lattanzi G.;... Sciandra M.; Serra M.; Colombo M.P.; Bernard A.; Picci P.; Scotlandi K. | 2006-01-01 | MOLECULAR BIOLOGY OF THE CELL | - | 1.01 Articolo in rivista | - |
| CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2. | Sciandra M;Marino MT;Manara MC;Guerzoni C;Grano M;Oranger A;Lucarelli E;Lollini PL;Dozza B;Pratel...li L;Renzo MF;Colombo MP;Picci P;Scotlandi K | 2014-01-01 | JOURNAL OF BONE AND MINERAL RESEARCH | - | 1.01 Articolo in rivista | - |
| CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity | Scotlandi K; Zuntini M; Manara MC; Sciandra M; Rocchi A; Benini S; Nicoletti G; Bernard G; Nanni ...P; Lollini PL; Bernard A; Picci P | 2007-01-01 | ONCOGENE | - | 1.01 Articolo in rivista | - |
| CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity. | Zucchini C;Manara MC;Pinca RS;De Sanctis P;Guerzoni C;Sciandra M;Lollini PL;Cenacchi G;Picci P;Va...lvassori L;Scotlandi K | 2014-01-01 | ONCOGENE | - | 1.01 Articolo in rivista | - |
| Cell growth inhibition and apoptotic effect of the rexinoid 6-OH-11-O-hydroxyphenantrene on human osteosarcoma and mesenchymal stem cells. | Dozza B.; Papi A.; Lucarelli E.; Scotlandi K.; Pierini M.; Tresca G.; Donati D.; Orlandi M. | 2012-01-01 | TOXICOLOGY IN VITRO | - | 1.01 Articolo in rivista | - |
| Characterization of human mesenchymal stem cells from Ewing sarcoma patients. Pathogenetic implications | Amaral, A.T.A.; Manara, M.C.; Berghuis, D.; Ordonez, J.L.; Biscuola, M.; Lopez-Garcia, M.A.; Osun...a, D.; Lucarelli, E.; Alviano, F.; Lankester, A.; Scotlandi, K.; De Alava, E. | 2014-01-01 | PLOS ONE | - | 1.01 Articolo in rivista | MSC Ewing Sarcoma Plos One_2014.pdf; pone.0085814.s001.tif; pone.0085814.s002.doc |
| Circulating miR34a levels as a potential biomarker in the follow-up of Ewing sarcoma | Sciandra M.; De Feo A.; Parra A.; Landuzzi L.; Lollini P.-L.; Manara M.C.; Mattia G.; Pontecorvi ...G.; Baricordi C.; Guerzoni C.; Bazzocchi A.; Longhi A.; Scotlandi K. | 2020-01-01 | JOURNAL OF CELL COMMUNICATION AND SIGNALING | - | 1.01 Articolo in rivista | - |
| Does MGMT (O6-methylguanine–DNA methyltransferase) have a role in metastatic Ewing sarcoma (ES) patients (pts) undergoing temozolomide (TMZ) and irinotecan (IRI)? | Emanuela Palmerini; Michela Pasello; Robin Lewis Jones; Maria Cristina Manara; Alessandro Parra; ...Piero Picci; Giovanni Grignani; Emanuela Marchesi; Marilena Cesari; Alessandra Longhi; Massimo Abate; Anna Paioli; Lorenzo D'Ambrosio; Franca Fagioli; Asaftei sebastian Dorin; Stefano Ferrari; Katia Scotlandi | 2017-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 4.03 Poster | - |
| Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation | De Feo A.; Sciandra M.; Ferracin M.; Felicetti F.; Astolfi A.; Pignochino Y.; Picci P.; Care A.; ...Scotlandi K. | 2019-01-01 | CELL DEATH & DISEASE | - | 1.01 Articolo in rivista | s41419-019-1675-1.pdf |
| Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cells. | Contaldo C;Myers TJ;Zucchini C;Manara MC;Chiodoni C;Colombo MP;Nicoletti G;Lollini PL;Li T;Longob...ardi L;Scotlandi K;Spagnoli A | 2014-01-01 | GROWTH FACTORS | - | 1.01 Articolo in rivista | - |
| Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells | Scotlandi K.; Avnet S.; Benini S.; Manara M.C.; Serra M.; Cerisano V.; Perdichizzi S.; Lollini P....-L.; De Giovanni C.; Landuzzi L.; Picci P. | 2002-01-01 | INTERNATIONAL JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| High metastatic efficiency of human sarcoma cells in Rag2/gamma c double knockout mice provides a powerful test system for antimetastatic targeted therapy | P. Nanni; G. Nicoletti; L. Landuzzi; S. Croci; A. Murgo; A. Palladini; A. Antognoli; M.L. Ianzano...; V. Stivani; V. Grosso; S.-M. Maira; C. García-Echeverría; K. Scotlandi; C. De Giovanni; P.-L. Lollini | 2010-01-01 | EUROPEAN JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Identification of candidate genes involved in the reversal of malignant phenotype of osteosarcoma cells transfected with the liver/bone/kidney alkaline phosphatase gene | ZUCCHINI C.; BIANCHINI M.; VALVASSORI L.; PERDICHIZZI S.; BENINI S.; MANARA MC.; SOLMI R.; STRIPP...OLI P.; PICCI P.; CARINCI P.; SCOTLANDI K. | 2004-01-01 | BONE | - | 1.01 Articolo in rivista | - |